Viking Therapeutics (VKTX) Shares Repurchased (2022)

Viking Therapeutics' Shares Repurchased history spans 2 years, with the latest figure at $1.7 million for Q2 2022.

  • For Q2 2022, Shares Repurchased changed N/A year-over-year to $1.7 million; the TTM value through Dec 2022 reached $6.8 million, changed N/A, while the annual FY2022 figure was $6.8 million, N/A changed from the prior year.
  • Shares Repurchased for Q2 2022 was $1.7 million at Viking Therapeutics, down from $5.1 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $5.1 million in Q1 2022 and bottomed at $1.7 million in Q2 2022.